National Institute on Drug Abuse
E9512
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
All labels observed (5)
How this entity was disambiguated
This entity first appeared as the object of triple T77687 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: National Institute on Drug Abuse Context triple: [National Institutes of Health, hasPart, National Institute on Drug Abuse]
-
A.
Substance Abuse and Mental Health Services Administration
The Substance Abuse and Mental Health Services Administration (SAMHSA) is a U.S. federal agency within the Department of Health and Human Services that leads national efforts to improve behavioral health and reduce the impact of substance abuse and mental illness.
-
B.
National Institute of Mental Health
The National Institute of Mental Health is a leading U.S. federal research agency dedicated to understanding, treating, and preventing mental illnesses.
-
C.
Office of National Drug Control Policy
The Office of National Drug Control Policy is a U.S. federal agency that coordinates and oversees national drug-control strategy and policies across the government.
-
D.
National Institutes of Health
The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
-
E.
Inter-American Drug Abuse Control Commission
The Inter-American Drug Abuse Control Commission is a specialized body of the Organization of American States that coordinates regional policies and programs to prevent and combat drug abuse and illicit trafficking in the Americas.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: National Institute on Drug Abuse Target entity description: The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
A.
Substance Abuse and Mental Health Services Administration
The Substance Abuse and Mental Health Services Administration (SAMHSA) is a U.S. federal agency within the Department of Health and Human Services that leads national efforts to improve behavioral health and reduce the impact of substance abuse and mental illness.
-
B.
National Institute of Mental Health
The National Institute of Mental Health is a leading U.S. federal research agency dedicated to understanding, treating, and preventing mental illnesses.
-
C.
Office of National Drug Control Policy
The Office of National Drug Control Policy is a U.S. federal agency that coordinates and oversees national drug-control strategy and policies across the government.
-
D.
National Institutes of Health
The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
-
E.
Inter-American Drug Abuse Control Commission
The Inter-American Drug Abuse Control Commission is a specialized body of the Organization of American States that coordinates regional policies and programs to prevent and combat drug abuse and illicit trafficking in the Americas.
- F. None of above. chosen
Statements (69)
| Predicate | Object |
|---|---|
| instanceOf |
U.S. federal research agency
ⓘ
addiction research institute ⓘ biomedical research organization ⓘ |
| abbreviation |
National Institute on Drug Abuse
self-linksurface differs
ⓘ
surface form:
NIDA
|
| aimsTo |
inform evidence-based prevention of drug use
ⓘ
inform evidence-based treatment of addiction ⓘ inform public health policy on drugs ⓘ reduce the health and social burden of drug use ⓘ |
| collaboratesWith |
Centers for Disease Control and Prevention
ⓘ
Food and Drug Administration ⓘ Substance Abuse and Mental Health Services Administration ⓘ World Health Organization ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| employerOf |
addiction researchers
ⓘ
clinical scientists ⓘ epidemiologists ⓘ health policy analysts ⓘ neuroscientists ⓘ |
| fieldOfWork |
addiction science
ⓘ
drug abuse research ⓘ epidemiology of drug use ⓘ health policy research ⓘ neuroscience of addiction ⓘ prevention science ⓘ public health ⓘ treatment of substance use disorders ⓘ |
| focusesOn |
HIV and other infectious diseases related to drug use
ⓘ
addiction ⓘ cannabis use and effects ⓘ drug use ⓘ health consequences of drug use ⓘ opioid use disorder ⓘ overdose ⓘ prescription drug misuse ⓘ stimulant use disorder ⓘ substance misuse ⓘ substance use disorders ⓘ tobacco and nicotine addiction ⓘ |
| foundedBy | United States Congress ⓘ |
| funds |
clinical trials on addiction treatment
ⓘ
extramural research grants ⓘ intramural research programs ⓘ prevention intervention studies ⓘ training grants for addiction researchers ⓘ |
| hasFormerName |
National Institute on Drug Abuse
self-linksurface differs
ⓘ
surface form:
National Institute on Drug Abuse of the Alcohol, Drug Abuse, and Mental Health Administration
|
| hasWebsite | https://nida.nih.gov ⓘ |
| headquartersLocation |
Bethesda, Maryland
ⓘ
Rockville, Maryland ⓘ |
| inception | 1974 ⓘ |
| jurisdiction |
United States government
ⓘ
surface form:
federal government of the United States
|
| languageOfWorkOrName | English ⓘ |
| locatedInTimeZone | Eastern Time Zone ⓘ |
| mission |
to advance science on drug use and addiction
ⓘ
to apply that knowledge to improve individual and public health ⓘ |
| operates |
National Institute on Drug Abuse
self-linksurface differs
ⓘ
surface form:
NIDA Clinical Trials Network
NIDA Drug Supply Program ⓘ NIDA International Program ⓘ extramural research program ⓘ intramural research program ⓘ |
| parentOrganization |
United States Department of Health and Human Services
ⓘ
surface form:
U.S. Department of Health and Human Services
|
| partOf | National Institutes of Health ⓘ |
| publishes |
NIDA Notes
ⓘ
National Institute on Drug Abuse self-linksurface differs ⓘ
surface form:
NIDA Research Reports
public education materials on drugs and addiction ⓘ |
| studies |
behavioral therapies for substance use disorders
ⓘ
brain mechanisms of addiction ⓘ genetic and environmental risk factors for substance use disorders ⓘ medications for addiction treatment ⓘ prevention strategies for youth drug use ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: National Institute on Drug Abuse Description of subject: The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
Referenced by (16)
Full triples — surface form annotated when it differs from this entity's canonical label.
National Institute on Drug Abuse
→
abbreviation
→
National Institute on Drug Abuse
self-linksurface differs
ⓘ
this entity surface form:
NIDA
National Institute on Drug Abuse
→
operates
→
National Institute on Drug Abuse
self-linksurface differs
ⓘ
this entity surface form:
NIDA Clinical Trials Network
National Institute on Drug Abuse
→
publishes
→
National Institute on Drug Abuse
self-linksurface differs
ⓘ
this entity surface form:
NIDA Research Reports
National Institute on Drug Abuse
→
hasFormerName
→
National Institute on Drug Abuse
self-linksurface differs
ⓘ
this entity surface form:
National Institute on Drug Abuse of the Alcohol, Drug Abuse, and Mental Health Administration
this entity surface form:
NIDA
NIDA Division of Therapeutics and Medical Consequences
→
partOf
→
National Institute on Drug Abuse
ⓘ
NIDA Division of Therapeutics and Medical Consequences
→
parentOrganization
→
National Institute on Drug Abuse
ⓘ
this entity surface form:
NIDA